Phase
Condition
Diabetes Mellitus, Type 1
Treatment
CGM and RPM
Clinical Study ID
Ages 6-21 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Inclusion criteria includes all youth with new onset T1D seen in the Stanford/Lucile Packard Children's Hospital ages 6 months-21 years of age. The program will also be offered to pediatric patients with existing T1D who wear a CGM or want to start a CGM and receive RPM. We intend to include all possible patients with the goal of maximizing generalizability of the results and 4T program. (NOTE: We will include children and families who speak all languages using the Stanford interpreter services so as to have the greatest generalizability of the research. Questionnaires will only be given to English and Spanish speakers.)
All individuals with a T1D diagnosis seen at the Stanford Children's Diabetes Clinic
Individuals who plan to receive follow-up care at the Stanford Children's DiabetesClinic
Individuals who agree to wear a CGM that will connect to the RPM-care model
Age: six months to < 21 years of age
Patient or guardian must own and operate a compatible smart device/phone to senddata from the CGM into the HIPAA-compliant RPM-care model for data analysis andreview by a care team member.
Dr. Maahs and Pediatric Endocrinology have philanthropic funds available topurchase compatible smart devices for participants who do not have a compatiblesmart device/phone.
Exclusion
Exclusion Criteria:
Diabetes diagnosis other than T1D
Individuals with the intention of obtaining diabetes care at another clinic
Individuals who do not consent to CGM use, CGM data integration, remote monitoring
Individuals > 21 years of age
Study Design
Study Description
Connect with a study center
Lucile Packard Children's Hospital
Palo Alto, California 94305
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.